Related references
Note: Only part of the references are listed.Small Molecules and Alzheimer’s Disease: Misfolding, Metabolism and Imaging
Viharkumar Patel et al.
Current Alzheimer Research (2016)
Dimethyl Fumarate: A Review in Relapsing-Remitting MS
Emma D. Deeks
DRUGS (2016)
Molecular similarity guided optimization of novel Nrf2 activators with 1,2,4-oxadiazole core
Li-Li Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery
Thomas G. Davies et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update
Meng-Chen Lu et al.
MEDICINAL RESEARCH REVIEWS (2016)
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
Ulf Schulze-Topphoff et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
A Small Molecule Inhibits Deregulated NRF2 Transcriptional Activity in Cancer
Michael J. Bollong et al.
ACS CHEMICAL BIOLOGY (2015)
The Keap1/Nrf2 pathway in health and disease: from the bench to the clinic
Maria A. O'Connell et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Peptide and small molecule inhibitors of the Keap1-Nrf2 protein-protein interaction
Geoff Wells
BIOCHEMICAL SOCIETY TRANSACTIONS (2015)
Heterocyclic chalcone activators of nuclear factor (erythroid-derived 2)-like 2 (Nrf2) with improved in vivo efficacy
Nicole Lounsbury et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway
B. G. Richardson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Novel Nrf2 activators from microbial transformation products inhibit blood-retinal barrier permeability in rabbits
Yasuhiro Nakagami et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators
Atul D. Jain et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Epigenetic regulation of Keap1-Nrf2 signaling
Yue Guo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
Adedamola Olayanju et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Molecular basis of the Keap1-Nrf2 system
Takafumi Suzuki et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
Synthesis of Piperlongumine Analogues and Discovery of Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators as Potential Neuroprotective Agents
Shoujiao Peng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Structure-Activity and Structure-Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1-Nrf2 Protein-Protein Interaction Inhibitor
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction
Helene C. Bertrand et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Discovery and Modification of in Vivo Active Nrf2 Activators with 1,2,4-Oxadiazole Core: Hits Identification and Structure-Activity Relationship Study
Li-Li Xu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
DIMETHYL FUMARATE ATTENUATES 6-OHDA-INDUCED NEUROTOXICITY IN SH-SY5Y CELLS AND IN ANIMAL MODEL OF PARKINSON'S DISEASE BY ENHANCING NRF2 ACTIVITY
X. Jing et al.
NEUROSCIENCE (2015)
Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation
Mikiya Satoh et al.
FEBS OPEN BIO (2015)
Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents
Dhulfiqar Ali Abed et al.
ACTA PHARMACEUTICA SINICA B (2015)
Protolichesterinic acid derivatives: α-Methylene-γ-lactones as potent dual activators of PPARγ and Nrf2 transcriptional factors
Anne-Cecile Le Lamer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex
Eric Jnoff et al.
CHEMMEDCHEM (2014)
Updated Research and Applications of Small Molecule Inhibitors of Keap1-Nrf2 Protein-Protein Interaction: a Review
Chunlin Zhuang et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1
Hye-Kyung Na et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Discovery of Potent Keap1-Nrf2 Protein-Protein Interaction Inhibitor Based on Molecular Binding Determinants Analysis
Zheng-Yu Jiang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
Anne Cleasby et al.
PLOS ONE (2014)
The cytoprotective and the dark side of Nrf2
R. Marchan et al.
ARCHIVES OF TOXICOLOGY (2013)
Structure activity relationship of phenolic diterpenes from Salvia officinalis as activators of the nuclear factor E2-related factor 2 pathway
Justin T. Fischedick et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism
Douglas Marcotte et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction
Longqin Hu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Synthesis and bioevaluation of a series of alpha-pyrone derivatives as potent activators of Nrf2/ARE pathway (part I)
Mei-yang Xi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
A Novel Semisynthetic Flavonoid 7-O-Galloyltaxifolin Upregulates Heme Oxygenase-1 in RAW264.7 Cells via MAPK/Nrf2 Pathway
Jiri Vrba et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
3-Aroylmethylene-2,3,6,7-tetrahydro-1H-pyrazino[2,1-a]isoquinolin-4(11bH)-ones as Potent Nrf2/ARE Inducers in Human Cancer Cells and AOM-DSS Treated Mice
Mei-yang Xi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease
Fabiana Morroni et al.
NEUROTOXICOLOGY (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Nrf2 in Host Defense: Over the Rainbow
Hye-Youn Cho et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
The Involvement of NRF2 in Lung Cancer
Alison K. Bauer et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
An effective strategy for increasing the radiosensitivity of Human lung Cancer cells by blocking Nrf2-dependent antioxidant responses
Saelooom Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
A Synthetic Chalcone as a Potent Inducer of Glutathione Biosynthesis
Remy Kachadourian et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
The cytoprotective role of the Keap1-Nrf2 pathway
Liam Baird et al.
ARCHIVES OF TOXICOLOGY (2011)
Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis
Tomasz M. Stepkowski et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Chemoenzymatic synthesis of (2R,3R,4R)-dehydroxymethylepoxyquinomicin (DHMEQ), a new activator of antioxidant transcription factor Nrf2
Yukihiro Niitsu et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease
A. Boutten et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Oxidative stress, inflammation, and cancer How are they linked?
Simone Reuter et al.
FREE RADICAL BIOLOGY AND MEDICINE (2010)
Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis
Deepti Malhotra et al.
NUCLEIC ACIDS RESEARCH (2010)
Electrophilic tuning of the chemoprotective natural product sulforaphane
Young-Hoon Ahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
The rise of antioxidant signaling-The evolution and hormetic actions of Nrf2
Jonathan Maher et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2010)
Nrf2 is a critical modulator of the innate immune response in a model of uveitis
Norihiro Nagai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Prohibitin Is a Novel Regulator of Antioxidant Response That Attenuates Colonic Inflammation in Mice
Arianne L. Theiss et al.
GASTROENTEROLOGY (2009)
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
Xiao-Jun Wang et al.
CARCINOGENESIS (2008)
Nrf2-induced antioxidant Protection: A Promising target to counteract ROS-mediated damage in neurodegenerative disease?
Helga E. de Vries et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Functional polymorphisms in the transcription factor NRF2 in humans increase the risk of acute lung injury
Jacqui M. Marzec et al.
FASEB JOURNAL (2007)
Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism
Kit I. Tong et al.
BIOLOGICAL CHEMISTRY (2006)
Structure of the Keap1: Nrf2 interface provides mechanistic insight into Nrf2 signaling
Shih-Ching Lo et al.
EMBO JOURNAL (2006)
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer
B Padmanabhan et al.
MOLECULAR CELL (2006)
Nrf2 as a target for cancer chemoprevention
X Yu et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome
Y Katoh et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
BTB protein keap1 targets antioxidant transcription factor nrf2 for ubiquitination by the cullin 3-Roc1 ligase
M Furukawa et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers
N Wakabayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: Oxidative stress sensing by a Cul3-Keap1 ligase
SB Cullinan et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron
M McMahon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex
DD Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Nrf2-Keap1 defines a physiologically important stress response mechanism
H Motohashi et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Chemoprevention of cancer - Focusing on clinical trials
T Kakizoe
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation
N Wakabayashi et al.
NATURE GENETICS (2003)
Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants
AT Dinkova-Kostova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system
M Kobayashi et al.
GENES TO CELLS (2002)
Role of phase 2 enzyme induction in chemoprotection by dithiolethiones
MK Kwak et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2001)
Acents, biomarkers, and cohorts for chemopreventive agent development in prostate cancer
GJ Kelloff et al.
UROLOGY (2001)
Oxidants, oxidative stress and the biology of ageing
T Finkel et al.
NATURE (2000)
Share Paper
